Eagle Pharmaceuticals shares owned by LSV Asset Management
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by LSV Asset Management
from 13F filings
Historical chart of LSV Asset Management investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by LSV Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Eagle Pharmaceuticals by LSV Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $1.7M | 295k | 5.60 |
2024-03-31 | $1.8M | 334k | 5.24 |
2023-12-31 | $2.0M | 392k | 5.23 |
2023-09-30 | $6.4M | 409k | 15.77 |
2023-06-30 | $7.9M | 409k | 19.44 |
2023-03-31 | $6.9M | 244k | 28.37 |
2022-12-31 | $4.4M | 151k | 29.23 |
2020-12-31 | $153k | 3.3k | 46.52 |
2020-09-30 | $586k | 14k | 42.46 |
2020-06-30 | $8.1M | 169k | 47.98 |
2020-03-31 | $15M | 320k | 46.00 |
2019-12-31 | $22M | 369k | 60.08 |
2019-09-30 | $26M | 462k | 56.57 |
2019-06-30 | $13M | 250k | 50.49 |
2019-03-31 | $13M | 250k | 50.49 |
2018-12-31 | $3.4M | 83k | 40.28 |
2018-09-30 | $6.2M | 89k | 69.33 |
2018-06-30 | $45M | 593k | 75.66 |
2018-03-31 | $45M | 859k | 52.69 |
2017-12-31 | $39M | 734k | 53.42 |
2017-09-30 | $14M | 228k | 59.64 |